Veradermics, Incorporated (MANE)
NYSE: MANE · Real-Time Price · USD
102.82
-2.50 (-2.37%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Veradermics Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Veradermics stock has a consensus rating of "Strong Buy" and an average price target of $163.5. The average 1-year stock price forecast is 59.02% higher than the current stock price, while the lowest is $135 (+31.30%) and the highest is $182 (+77.01%).
Price Target: $163.5 (+59.02%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Veradermics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 6 | 6 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $160 | Buy | Maintains | $160 | +55.61% | Aug 13, 2026 |
| Needham | Needham | Buy Maintains $164 | Buy | Maintains | $164 | +59.50% | Aug 12, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $170 | Buy | Maintains | $170 | +65.34% | Aug 11, 2026 |
| Jefferies | Jefferies | Buy Maintains $182 | Buy | Maintains | $182 | +77.01% | Jul 16, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Initiates $170 | Buy | Initiates | $170 | +65.34% | Jul 15, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
8.66M
EPS This Year
-2.94
from -111.91
EPS Next Year
-2.69
from -2.94
EPS and Forward PE are based on non-GAAP adjusted numbers.